Table 1.
Clinical and histopathological details of the samples.
| ID | Sex | Laterality | Age at Presentation | Clinical Risk | IIRC Group | AJCC Staging |
|---|---|---|---|---|---|---|
| P1 | M | Bilateral | 15 months | Advanced | Group E | cT3b |
| P2 | F | Unilateral | 20 months | Advanced | Group E | cT3b |
| P3 | M | Unilateral | 24 months | Advanced | Group E | cT3a |
| P4 | F | Bilateral | 4 months | Advanced | Group E | cT3b |
| P5 | M | Bilateral | 30 months | Advanced | Group E | cT3b |
| P6 | F | Bilateral | 21 months | Non-advanced | Group D | cT2b |
| P7 | F | Unilateral | 28 months | Non-advanced | Group D | cT2b |
| P8 | M | Unilateral | 20 months | Non-advanced | Group D | cT2b |
| P9 | M | Unilateral | 21 months | Non-advanced | Group D | cT2a |
| Control 1 | F | NA | 3 months | Cardiac arrest (no ocular complications) | ||
| Control 2 | F | NA | 2 months | Multiple organ dysfunction (no ocular complications) | ||